Spitzoid Lesions Diagnosis based on GA feature selection and Random Forest
Authors:
Abir Belaala,
Labib Sadek,
Noureddine Zerhouni,
Christine Devalland
Abstract:
Spitzoid lesions broadly categorized into Spitz Nevus (SN), Atypical Spitz Tumors (AST), and Spitz Melanomas (SM). The accurate diagnosis of these lesions is one of the most challenges for dermapathologists; this is due to the high similarities between them. Data mining techniques are successfully applied to situations like these where complexity exists. This study aims to develop an artificial in…
▽ More
Spitzoid lesions broadly categorized into Spitz Nevus (SN), Atypical Spitz Tumors (AST), and Spitz Melanomas (SM). The accurate diagnosis of these lesions is one of the most challenges for dermapathologists; this is due to the high similarities between them. Data mining techniques are successfully applied to situations like these where complexity exists. This study aims to develop an artificial intelligence model to support the diagnosis of Spitzoid lesions. A private spitzoid lesions dataset have been used to evaluate the system proposed in this study. The proposed system has three stages. In the first stage, SMOTE method applied to solve the imbalance data problem, in the second stage, in order to eliminate irrelevant features; genetic algorithm is used to select significant features. This later reduces the computational complexity and speed up the data mining process. In the third stage, Random forest classifier is employed to make a decision for two different categories of lesions (Spitz nevus or Atypical Spitz Tumors). The performance of our proposed scheme is evaluated using accuracy, sensitivity, specificity, G-mean, F- measure, ROC and AUC. Results obtained with our SMOTE-GA-RF model with GA-based 16 features show a great performance with accuracy 0.97, F-measure 0.98, AUC 0.98, and G-mean 0.97.Results obtained in this study have potential to open new opportunities in diagnosis of spitzoid lesions.
△ Less
Submitted 3 June, 2020; v1 submitted 10 March, 2020;
originally announced March 2020.
